Piper Jaffray Would Be Buyers of Myriad Genetics (MYGN) On Today's Sell-Off
Tweet Send to a Friend
Piper Jaffray lowered their price target on Myriad Genetics Inc. (Nasdaq: MYGN) from $69 to $56 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
